SARS-CoV-2 Omicron XBB.1.5, CA.3.1, and CH.1.1 exhibit remarkable antibody resistance

In a recent study posted to bioRxiv* preprint server, researchers at Ohio State University examined the degree of neutralizing antibody (nAb) evasion by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron XBB.1.5, CA.3.1, and CH.1.1 subvariants.

Related Keywords

India ,United States , ,Ohio State University ,Extraordinary Evasion ,Neutralizing Antibody Response ,Image Credit ,Industry Focus ,Antibody ,Coronavirus Disease Covid 19 ,Micron ,Cars ,Ars Cov 2 ,Ce2 ,Antibodies ,Fell ,Cell Line ,Coronavirus ,Efficacy ,Immunity ,Espiratory ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,Vaccine ,